Inhibrx Biosciences (INBX) Stock: Buy, Sell, or Hold?
INBX - Inhibrx Biosciences, Inc. Common Stock
$109.27
-2.15 (-1.93%)
▼
5d:
-10.62%
30d:
+11.09%
90d:
+16.82%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 12, 2026
0d
Get Alerted When INBX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: INBX is down 10.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: INBX is down 10.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: INBX is currently trading at $109.27, which is considered slightly high relative to its 30-day fair value range of $87.81 to $119.69.
Technical Outlook: Technically, INBX is in a downtrend. Immediate support is located at $94.00, while resistance sits at $129.88.
Market Sentiment: INBX scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $266.67 (+144.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, INBX is in a downtrend. Immediate support is located at $94.00, while resistance sits at $129.88.
Market Sentiment: INBX scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $266.67 (+144.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$87.81 -
$119.69
Company Quality Score
40/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
42.1%
Protect Your Profits
Holding INBX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 144.0% below Wall St target ($266.67)
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$87.81 -
$119.69
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$94.00
Resistance Level
$129.88
Current Trend
Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-12.47
Wall Street Target
$266.67
(+144.0%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: September 12, 2026 3:23 AM ET
Data refreshes hourly during market hours. Next update: 4:23 AM
Data refreshes hourly during market hours. Next update: 4:23 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INBX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 52 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 50 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 49 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 50 HOLD |
Advanced INBX Option Strategies
Professional options setups generated by AI based on today's INBX price and gamma walls.
